Position in PFE
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$288,309
-$32,729 QoQ
Shares Held
11,973
+4.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#2,155
of 2,821 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 51%
Shared 0%
None 49%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Weaver Consulting Group holds $4,407,808 across 7 Drug Manufacturers - General names. PFE ranks #7 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
5,013 | $1,273,151 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
6,077 | $767,768 | |
| 3 | LLY |
ELI LILLY & Co
|
551 | $660,885 | |
| 4 | AMGN |
Amgen Inc
|
1,633 | $591,341 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,026 | $517,341 | |
| 6 | ABBV |
AbbVie Inc.
|
1,228 | $309,013 | |
| 7 | PFE |
Pfizer Inc
This page
|
11,973 | $288,309 |
All Filings in PFE
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $288,309 | 11,973 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $321,038 | 11,433 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $278,606 | 11,189 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $243,002 | 9,537 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $246,205 | 10,157 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $262,699 | 10,367 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $283,207 | 10,675 | Shares | Sole | 2025-01-08 | |
| 2024-09-30 | $385,278 | 13,313 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $370,679 | 13,248 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $361,360 | 13,022 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $289,109 | 10,042 | Shares | Sole | 2024-01-22 | |
| 2023-03-31 | $211,303 | 5,179 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $285,714 | 5,576 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $243,218 | 5,558 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $295,600 | 5,638 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $297,832 | 5,753 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $363,098 | 6,149 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $266,618 | 6,199 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $240,559 | 6,143 | Shares | Sole | 2021-07-06 | |
| 2021-03-31 | $230,567 | 6,364 | Shares | Sole | 2021-04-07 | |
| 2020-12-31 | $213,166 | 5,791 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $202,216 | 5,510 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $180,177 | 5,510 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $170,021 | 5,209 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||